C J Estol. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Anticoagulants/administration & dosageAnticoagulants/adverse effectsCerebral Hemorrhage/etiologyCerebral Hemorrhage/prevention & controlCohort StudiesHeparin/administration & dosageHeparin/adverse effectsHumansInjections, IntravenousRandomized Controlled Trials as TopicSecondary PreventionStroke/complicationsStroke/drug therapy
Substances: See more » AnticoagulantsHeparin
Year: 2000 PMID: 10751280 DOI: 10.1212/wnl.54.7.1542
Source DB: PubMed Journal: Neurology ISSN: 0028-3878 Impact factor: 9.910